Jelleine‑I Membrane Interaction-related Biological Properties and Antimicrobial Activity against MDR, XDR, and PDR-Acinetobacter baumannii Clinical Isolates

Jelleine‑I Membrane Interaction-related Biological Properties and Antimicrobial Activity against MDR, XDR, and PDR-Acinetobacter baumannii Clinical Isolates

Saved in:

Bibliographic Details
Main Authors:	Adrielle Pieve de Castro, Julio Cesar Moreira Brito, Wanderson Aparecido Brandão Candido, Amanda Souza Félix, Rodrigo Moreira Verly, Jarbas Magalhães Resende, Letícia Lopes-de-Souza, Carlos Chávez-Olórtegui, Simone Odília Antunes Fernandes, Valbert Nascimento Cardoso
Format:	Article
Language:	English
Published:	American Chemical Society 2025-03-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.4c09073
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of Acinetobacter baumannii and Determination of MDR and XDR Strains
by: Noor Hussein Ahmad, et al.
Published: (2020-07-01)

Production and Extraction of Siderophores-Catecholate- from -MDR-Acinetobacter baumannii
by: Baghdad Science Journal
Published: (2017-06-01)

Antibacterial Activity of Jelleine-I, a Peptide Isolated from Royal Jelly of <i>Apis mellifera</i>, Against Colistin-Resistant <i>Klebsiella pneumoniae</i>
by: William Gustavo Lima, et al.
Published: (2025-06-01)

Transmission of MDR and XDR tuberculosis in Shanghai, China.
by: Ming Zhao, et al.
Published: (2009-01-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

INDIVIDUAL TREATMENT OF PULMONARY MDR/XDR TUBERCULOSIS IN ADOLESCENTS
by: L. V. Pаnovа, et al.
Published: (2018-03-01)

Treatment Results in Patients with Drug Resistant Tuberculosis (MDR, pre-XDR, XDR) and HIV Infection in Stavropol Region
by: N. A. Sosova, et al.
Published: (2024-07-01)

Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB
by: Natalia Zaporojan, et al.
Published: (2025-07-01)

Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities
by: Kai Ling Chin, et al.
Published: (2024-01-01)

The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections
by: Stefano Busani, et al.
Published: (2017-01-01)

Mathematical Model of MDR-TB and XDR-TB with Isolation and Lost to Follow-Up
by: F. B. Agusto, et al.
Published: (2015-01-01)

The effect of the current chemotherapy of MDR/XDR tuberculosis on QT interval changes in ECG
by: E. M. Zhukova, et al.
Published: (2019-12-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings
by: A. V. Kukurika, et al.
Published: (2022-12-01)

Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01)

Fluopsin C Promotes Biofilm Removal of XDR <i>Acinetobacter baumannii</i> and Presents an Additive Effect with Polymyxin B on Planktonic Cells
by: Leandro Afonso, et al.
Published: (2024-09-01)

Active phytoconstituents to tackle the resistance mechanism of MDR and XDR bacteria: A critical review
by: Subhasmita Mallik, et al.
Published: (2025-08-01)

The efficacy of all-oral shorter MDR-TB and pre-XDR TB treatment in Russia
by: Anna Abramchenko, et al.
Published: (2024-12-01)

The growing concern of MDR/XDR bacteria in patients undergoing dialysis: a cross-sectional study
by: Noor S. Kadhem, et al.
Published: (2025-06-01)

Experience of using a combination mucoactive drug during chemotherapy in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2020-08-01)

Biosynthesis of TiO2 nanoparticles using prodigiosin and evaluating its antibacterial activity against biofilm producing MDR- Acinetobacter baumannii
by: Ahmed, Dalia, et al.
Published: (2020-12-01)

Salvage Therapy Against Infections of MDR <i>Acinetobacter baumannii</i> Achieved by Synergistic Effect of Colistin-Containing Therapies—Preliminary Study
by: Paweł Kmiecikowski, et al.
Published: (2025-05-01)

An MFS Transporter-Like ORF from MDR Acinetobacter baumannii AIIMS 7 Is Associated with Adherence and Biofilm Formation on Biotic/Abiotic Surface
by: Praveen K. Sahu, et al.
Published: (2012-01-01)

The response to desiccation in Acinetobacter baumannii
by: Massimiliano Lucidi, et al.
Published: (2025-12-01)

Investigation of Therapeutic Efficacy of Intravesical Tigecycline Administration in Rats with Cystitis Induced by Extensively Drug-Resistant (XDR), Tigecycline-Sensitive <i>Acinetobacter baumannii</i> Strain
by: Cihan Yüksel, et al.
Published: (2025-06-01)

Comparative analysis of eﬃcacy and safety of various anti-tuberculosis therapy regimens in patients with MDR/XDR tuberculosis
by: E. P. Myshkova, et al.
Published: (2022-06-01)

Multidrug-Resistant Acinetobacter baumannii mediastinitis
by: Selman Dumani, et al.
Published: (2024-07-01)

INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII IN CANCER PATIENTS
by: N. V. Dmitrieva, et al.
Published: (2019-06-01)

Influence of Cold Atmospheric Plasma on Acinetobacter baumannii
by: Atta et al.
Published: (2019-03-01)

Acinetobacter baumannii in Localised Cutaneous Mycobacteriosis in Falcons
by: Margit Gabriele Muller, et al.
Published: (2010-01-01)

Carbapenem Resistance in <i>Acinetobacter baumannii</i>: Mechanisms, Therapeutics, and Innovations
by: Joyce de Souza, et al.
Published: (2025-06-01)

Experiences and needs of patients with MDR/XDR-TB: a qualitative study among Saharia tribe in Madhya Pradesh, Central India
by: Samridhi Nigam, et al.
Published: (2021-08-01)

Acinetobacter baumannii Infection and IL-17 Mediated Immunity
by: Zihe Yan, et al.
Published: (2016-01-01)

<i>Acinetobacter baumannii</i>: Mechanisms of Antimicrobial Resistance
by: N. E. Barantsevich, et al.
Published: (2025-04-01)

Successful treatment of multidrug resistant Acinetobacter baumannii meningitis
by: Suzan Saçar, et al.
Published: (2007-12-01)

OXA-type carbapenemases in Acinetobacter baumannii in South America
by: Andrés Opazo, et al.
Published: (2011-12-01)

Identification of Antibiotic Resistance of Acinetobacter baumannii in Iraqi Patients
by: Maha E. Zidan, et al.
Published: (2022-11-01)

Detection of plasmid-borne mcr genes conferring colistin resistance in MDR and XDR Gram-negative bacterial isolates from an Egyptian hospital
by: Doaa Yousef, et al.
Published: (2025-08-01)

Molecular and genomic insights into multidrug-resistant (MDR) and extensively drug-resistant (XDR) Pseudomonas aeruginosa causing burn wound infections in Bangladesh
by: Spencer Mark Mondol, et al.
Published: (2025-07-01)

Drug resistance pattern of <i>M. tuberculosis</i> in those who developed the disease after exposure to MDR/XDR pulmonary tuberculosis
by: K. A. Glebov, et al.
Published: (2020-01-01)